Table 6: Within group comparisons - time points for the appearance of statistically significant differences in clinical (PW-VAS; WOMAC-C), laboratory (sCTX-I; uCTX-II) and radiographic (BMD; JSN; mJSW) indicators between different patterns of the same radiographic grade under the different intra-articular treatment.

#-Applied treatment

DM

p-values (‘H’ vs. ‘I’)

NS

p-values (‘H’ vs. ‘I’ vs. ‘A’)

HA

p-values (‘H’ vs. ‘I’ vs. ‘A’)

X-Ray grade

K/L -II

K/L -III

K/L -II

K/L -III

K/L -II

K/L -III

Indicator

 

PW-VAS /

WOMAC-C

M3 (p = 0.001)

M12

(p = 0.04)

M9

(p = 0.03)

M24

(p = 0.04)

M12

(p = 0.03)

sCTX-I

uCTX-II

M6 (p = 0.04)

M12

(p = 0.04)

M9

(p = 0.03)

M24

(p = 0.04)

M12

(p = 0.03)

TB-BMD

M24 (p = 0.04)

M48

(p = 0.04)

M36

(p = 0.03)

M48

(p = 0.03)

M36

(p = 0.04)

JSN

M12 (p = 0.02)

M36

(p = 0.04)

M24

(p = 0.03)

M48

(p = 0.03)

M36

(p = 0.03)

mJSW

M36 (p = 0.009)

M24

(p = 0.02)

M48

(p = 0.04)

M36

(p = 0.03)

M60

(p = 0.03)

M48

(p = 0.005)

PW - pain at walking by VAS; WOMAC-C - WOMAC function scale; NS - control group; DM - Depo Medrol (CS) group; HA - MMW-HA (Euflexxa group); #- Each study subgroup included 25 subjects; †-Mann-Wythney test with Dunn-Bonferroni post hoc analysis; ‡-Kruskal-Wallis test with Dunn-Bonferroni post hoc analysis; III/II -radiographic grade III /II -according to Kellgren-Lawrence; ‘A ‘; ‘I’; ‘H’ - atrophic, normotrophic, hypertrophic patterns.